Further studies will be required to fully determine the role of the investigational agent darusentan in resistant hypertension, say the authors of a phase 3 study with the drug. Heartwire
A new study suggests that adolescents with a possible genetic risk for alcoholism demonstrate greater frontal lobe activity during response inhibition than those without this history. Medscape Medical News
This study stands as a potentially very important advance -- not only in DMD, but as part of a broader quest for successful gene therapies. AccessMedicine from McGraw-Hill
Researchers have used an animal model to test a new type of biomaterial that may represent an advance over current brain monitoring technology. Medscape Medical News
